Articles for the ‘’ Category

Significant Turnaround in Russian Antitrust Practice of Protecting the Exclusivity of Drugs

Published 01 November 2024 by Boris Malakhov Lidings, Russia

Despite the fact that the issue of intellectual property rights turnover is included in the perimeter of antimonopoly regulation, until recently the Russian Antitrust Agency took rather an observant position.

The regulator’s position was that the issue of patent infringement is a private legal dispute between original and generic manufacturers, which should not affect the turnover of drugs, particularly the execution of contracts based on the results of public procurement. Only in isolated cases the Russian Antitrust Agency has established the fact of patent infringement and issued a corresponding order on the inadmissibility of anti-competitive practices.

Now the reverse trend has clearly emerged.

More in our update.

... Read more

Changes In Regulatory Framework for Dietary Supplements in Russia: What Is to Be Expected?

Published 11 September 2024 by Changes In Regulatory Framework for Dietary Supplements in Russia: What Is to Be Expected? Lidings, Russia

On 9 July 2024, the State Duma passed Bill in first reading, which focuses on changes in the regulatory regime for the circulation of dietary supplements in Russia.

The proposed amendments would introduce significant changes affecting the circulation of dietary supplements and, to a certain extent, bringing it closer to the regime established for pharmaceuticals and medical devices.

... Read more

Legal Digest: Patent Disputes in Life Sciences (November 2023)

Published 16 November 2023 by Boris Malakhov Lidings, Russia

Global pharmaceutical industry has become the field for serious patent-related battles between producers of original drugs and manufacturers of generics.

Particularly this trend is widely observed in EAEU and CIS, where the regulatory bodies and courts have not yet developed an efficient mechanism for maintaining the balance of interests between the pharmaceutical businesses, state and patients.

Having vast expertise in providing legal protection to large Russian and international pharmaceuticals and healthcare companies in EAEU and CIS, Lidings publishes Legal Digest highlighting the most notable patents disputes in Life Sciences that have been recently taking place in those jurisdictions.

... Read more